stars 1 stars 2 stars 3

Disruptive hip implant solution provides autonomy for life Orthonova commercialises a disruptive hip implant system for young patients in need of a hip surgery. Hip implants have a limited lifespan and young patients will have to replace their artificial hip before the end of their life. Classic implants are quite big and invasive, they sacrifice patients' bone and when they fail, a revision surgery can become a complex procedure with further clinical complications. Orthonova has solved this problem: Based on 30 years of clinical research, we have shown that our hip implant design is preserving young patients’ bone over time. As each patient is unique, Orthonova now provides a single use and patient specific instrumentation: "the surgery becomes simpler and safer than ever before" A perfect fit and bone conserving hip solution will last longer. Orthonova preserves young patients' autonomy for life.

Orthonova Questions

The Orthonova annual revenue was $3 million in 2026.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users